171 related articles for article (PubMed ID: 27216550)
1. Association Between Aerobic Exercise and Rosiglitazone Avoided the NAFLD and Liver Inflammation Exacerbated in PPAR-α Knockout Mice.
Batatinha HA; Lima EA; Teixeira AA; Souza CO; Biondo LA; Silveira LS; Lira FS; Rosa Neto JC
J Cell Physiol; 2017 May; 232(5):1008-1019. PubMed ID: 27216550
[TBL] [Abstract][Full Text] [Related]
2. Aerobic training improves NAFLD markers and insulin resistance through AMPK-PPAR-α signaling in obese mice.
Diniz TA; de Lima Junior EA; Teixeira AA; Biondo LA; da Rocha LAF; Valadão IC; Silveira LS; Cabral-Santos C; de Souza CO; Rosa Neto JC
Life Sci; 2021 Feb; 266():118868. PubMed ID: 33310034
[TBL] [Abstract][Full Text] [Related]
3. Singular effects of PPAR agonists on nonalcoholic fatty liver disease of diet-induced obese mice.
Barbosa-da-Silva S; Souza-Mello V; Magliano DC; Marinho Tde S; Aguila MB; Mandarim-de-Lacerda CA
Life Sci; 2015 Apr; 127():73-81. PubMed ID: 25748419
[TBL] [Abstract][Full Text] [Related]
4. Concurrent exercise improves insulin resistance and nonalcoholic fatty liver disease by upregulating PPAR-γ and genes involved in the beta-oxidation of fatty acids in ApoE-KO mice fed a high-fat diet.
Zheng F; Cai Y
Lipids Health Dis; 2019 Jan; 18(1):6. PubMed ID: 30611282
[TBL] [Abstract][Full Text] [Related]
5. GCN2 Deficiency Enhances Protective Effects of Exercise on Hepatic Steatosis.
Luo X; Shi X; Sun Z; Xiao J; Song H; Lu G; Xu X
Biomed Res Int; 2020; 2020():1454396. PubMed ID: 33299856
[TBL] [Abstract][Full Text] [Related]
6. Palmitoleic Acid Improves Metabolic Functions in Fatty Liver by PPARα-Dependent AMPK Activation.
de Souza CO; Teixeira AAS; Biondo LA; Lima Junior EA; Batatinha HAP; Rosa Neto JC
J Cell Physiol; 2017 Aug; 232(8):2168-2177. PubMed ID: 27925195
[TBL] [Abstract][Full Text] [Related]
7. Nicotinic acetylcholine receptor α7 subunit improves energy homeostasis and inhibits inflammation in nonalcoholic fatty liver disease.
Li DJ; Liu J; Hua X; Fu H; Huang F; Fei YB; Lu WJ; Shen FM; Wang P
Metabolism; 2018 Feb; 79():52-63. PubMed ID: 29129819
[TBL] [Abstract][Full Text] [Related]
8. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
[TBL] [Abstract][Full Text] [Related]
9. LPSF/GQ-02 inhibits the development of hepatic steatosis and inflammation in a mouse model of non-alcoholic fatty liver disease (NAFLD).
Soares e Silva AK; de Oliveira Cipriano Torres D; dos Santos Gomes FO; dos Santos Silva B; Lima Ribeiro E; Costa Oliveira A; dos Santos LA; de Lima Mdo C; Pitta Ida R; Peixoto CA
PLoS One; 2015; 10(4):e0123787. PubMed ID: 25875942
[TBL] [Abstract][Full Text] [Related]
10. Effect of an acute moderate-exercise session on metabolic and inflammatory profile of PPAR-α knockout mice.
Silveira LS; Pimentel GD; Souza CO; Biondo LA; Teixeira AAS; Lima EA; Batatinha HAP; Rosa Neto JC; Lira FS
Cell Biochem Funct; 2017 Dec; 35(8):510-517. PubMed ID: 29063619
[TBL] [Abstract][Full Text] [Related]
11. Sesamin ameliorates hepatic steatosis and inflammation in rats on a high-fat diet via LXRα and PPARα.
Zhang R; Yu Y; Hu S; Zhang J; Yang H; Han B; Cheng Y; Luo X
Nutr Res; 2016 Sep; 36(9):1022-1030. PubMed ID: 27632923
[TBL] [Abstract][Full Text] [Related]
12. Weight loss enhances hepatic antioxidant status in a NAFLD model induced by high-fat diet.
Mendes IKS; Matsuura C; Aguila MB; Daleprane JB; Martins MA; Mury WV; Brunini TMC
Appl Physiol Nutr Metab; 2018 Jan; 43(1):23-29. PubMed ID: 28834687
[TBL] [Abstract][Full Text] [Related]
13. Thymoquinone alleviates nonalcoholic fatty liver disease in rats via suppression of oxidative stress, inflammation, apoptosis.
Awad AS; Abd Al Haleem EN; El-Bakly WM; Sherief MA
Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):381-91. PubMed ID: 26753695
[TBL] [Abstract][Full Text] [Related]
14. Alpinetin improved high fat diet-induced non-alcoholic fatty liver disease (NAFLD) through improving oxidative stress, inflammatory response and lipid metabolism.
Zhou Y; Ding YL; Zhang JL; Zhang P; Wang JQ; Li ZH
Biomed Pharmacother; 2018 Jan; 97():1397-1408. PubMed ID: 29156529
[TBL] [Abstract][Full Text] [Related]
15. Sake lees extract improves hepatic lipid accumulation in high fat diet-fed mice.
Kubo H; Hoshi M; Matsumoto T; Irie M; Oura S; Tsutsumi H; Hata Y; Yamamoto Y; Saito K
Lipids Health Dis; 2017 Jun; 16(1):106. PubMed ID: 28578672
[TBL] [Abstract][Full Text] [Related]
16. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation.
Andrade JM; Paraíso AF; de Oliveira MV; Martins AM; Neto JF; Guimarães AL; de Paula AM; Qureshi M; Santos SH
Nutrition; 2014; 30(7-8):915-9. PubMed ID: 24985011
[TBL] [Abstract][Full Text] [Related]
18. Rosuvastatin as a potential preventive drug for the development of hepatocellular carcinoma associated with non-alcoholic fatty liver disease in mice.
Yokohama K; Fukunishi S; Ii M; Nakamura K; Ohama H; Tsuchimoto Y; Asai A; Tsuda Y; Higuchi K
Int J Mol Med; 2016 Nov; 38(5):1499-1506. PubMed ID: 28025996
[TBL] [Abstract][Full Text] [Related]
19. Palmitoleic acid reduces high fat diet-induced liver inflammation by promoting PPAR-γ-independent M2a polarization of myeloid cells.
Souza CO; Teixeira AAS; Biondo LA; Silveira LS; de Souza Breda CN; Braga TT; Camara NOS; Belchior T; Festuccia WT; Diniz TA; Ferreira GM; Hirata MH; Chaves-Filho AB; Yoshinaga MY; Miyamoto S; Calder PC; Sethi JK; Rosa Neto JC
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Oct; 1865(10):158776. PubMed ID: 32738301
[TBL] [Abstract][Full Text] [Related]
20. Pioglitazone attenuates hepatic inflammation and fibrosis in phosphatidylethanolamine N-methyltransferase-deficient mice.
van der Veen JN; Lingrell S; Gao X; Quiroga AD; Takawale A; Armstrong EA; Yager JY; Kassiri Z; Lehner R; Vance DE; Jacobs RL
Am J Physiol Gastrointest Liver Physiol; 2016 Apr; 310(7):G526-38. PubMed ID: 26797396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]